Immunovant (NasdaqGS:IMVT) Q2 2026 Earnings Call November 10, 2025 08:00 AM ET Company ParticipantsStephanie Lee - COOMatt Gline - CEOConference Call ParticipantsYaron Werber - AnalystCorinne Jenkins - AnalystBrian Cheng - AnalystDouglas Tsao - AnalystPrakhar Agrawal - AnalystBrandon Frith - AnalystNone - AnalystDominic Lorenzi - AnalystThomas Smith - AnalystDave Risinger - AnalystDennis Ding - AnalystSamantha Semenkow - AnalystNone - AnalystOperatorGood day, and thank you for standing by. Welcome to Immuno ...